<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Enhanced recovery after gynecologic surgery: Components and implementation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Enhanced recovery after gynecologic surgery: Components and implementation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Enhanced recovery after gynecologic surgery: Components and implementation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mallika Anand, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Emanuel C Trabuco, MD, MS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Girish P Joshi, MB, BS, MD, FFARCSI</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tommaso Falcone, MD, FRCSC, FACOG</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 25, 2020.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2377347492"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Enhanced recovery after surgery (ERAS) programs are perioperative protocols of evidence-based interventions that have been grouped together with the goals of speeding functional recovery and improving postoperative outcomes. Also known as "enhanced recovery protocols" (ERP) or "fast-track surgery," ERAS programs typically include multidisciplinary and multimodal interventions aimed at minimizing the physiologic changes associated with surgery. Patient benefits associated with ERAS include reduction in postoperative opioid use and length of stay.</p><p>This topic will review ERAS programs as they apply to gynecologic surgery with a planned overnight stay, although many elements of the ERAS programs discussed here can be adapted for same-day major gynecologic surgery, such as same-day hysterectomy. Related topics on ERAS in colorectal surgery and general postoperative care are presented separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">"Enhanced recovery after colorectal surgery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">"Overview of post-anesthetic care for adult patients"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15073.html" rel="external">"Overview of postoperative fluid therapy in adults"</a>.)</p><p></p><p class="headingAnchor" id="H3448018794"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>ERAS programs combine evidence-based elements of care during the pre-, intra-, and postoperative experiences to decrease physiological stress and organ dysfunction, and thus, enable patients to recover more quickly, have decreased hospital length of stay, and resume routine activity more quickly than with standard surgical care [<a href="#rid1">1</a>]. The patient is a fundamental component of ERAS protocols and is involved in every step from the decision for surgery through discharge. Importantly, elements of ERAS pathways will continue to evolve as new evidence emerges.</p><p>The initial ERAS outlined techniques to decrease perioperative physiologic stress to reduce perioperative morbidity and mortality, accelerate recovery, and decrease cost of care [<a href="#rid2">2</a>]. Founded in 2010, the ERAS Society develops international consensus guidelines and resources for the implementation of ERAS bundles [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H4067969844"><span class="h1">CANDIDATES</span><span class="headingEndMark"> — </span>Patients undergoing planned gynecologic surgery with an overnight stay are candidates for participation in an ERAS protocol. Although an ERAS pathway can broadly apply to the majority of patients undergoing gynecologic surgery, such a pathway should always be individualized when and where medically indicated. As examples, older adult patients or patients with renal or hepatic dysfunction may require dose adjustment (or elimination) of certain medications (eg, nonsteroidal anti-inflammatory drugs, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>).</p><p class="headingAnchor" id="H735063187"><span class="h1">COMPONENTS</span><span class="headingEndMark"> — </span>ERAS protocols vary among subspecialties, surgical routes, and institutions [<a href="#rid4">4-7</a>]. In general, enhanced recovery focuses on optimizing patient education and perioperative expectations, decreasing the perioperative fasting period, maintaining euvolemia and normothermia, increasing mobilization, providing multimodal pain relief, providing multimodal nausea and vomiting prophylaxis, and decreasing unnecessary or prolonged use of catheters and drains [<a href="#rid8">8</a>]. A guideline of general components for gynecologic surgery has been published by the ERAS Society (<a class="graphic graphic_table graphicRef113768" href="/z/d/graphic/113768.html" rel="external">table 1</a>) [<a href="#rid9">9,10</a>]. Modified guidelines have been proposed for gynecologic oncology patients [<a href="#rid11">11</a>]. Importantly, while ERAS pathways are formalized for the sake of standardization and ease of ordering, careful attention should be placed to ensure that each component is ultimately safe and applicable to the individual patient undergoing the specific surgery performed.</p><p class="headingAnchor" id="H899709435"><span class="h2">Preoperative</span></p><p class="headingAnchor" id="H1349751147"><span class="h3">Patient education</span><span class="headingEndMark"> — </span>Preoperative education sets patient expectations for the surgery and recovery process, which may in turn reduce fear, fatigue, and pain while increasing early discharge [<a href="#rid12">12</a>]. Effective patient education can take many forms, including access to on-line care modules [<a href="#rid13">13</a>]. One author's institution takes a fourfold approach to patient education that includes:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgeon's office</strong> – The surgeon discusses with the patient that she will be on an enhanced recovery pathway to facilitate surgical recovery and sets the expectation of discharge on the morning of postoperative day 1. The surgeon also informs the patient of the postoperative follow-up plan, including a postoperative phone call from the surgeon's office within two to three days following hospital discharge, as well as scheduled postoperative visits.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preprocedure assessment visit with the anesthesiology team</strong> – Patients on the ERAS pathway receive a 15-minute educational session about the ERAS pathway from a nurse practitioner in addition to undergoing a separate presurgical risk assessment if medically indicated.</p><p></p><p class="bulletIndent1">Information provided includes the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Preoperatively, the patient may eat solid food until midnight the night before surgery.</p><p class="bulletIndent3"><span class="glyph">-</span>She may drink only clear liquids until two hours before surgery.</p><p class="bulletIndent3"><span class="glyph">-</span>She will receive <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> soap with which she should cleanse the night before and the morning of surgery.</p><p class="bulletIndent3"><span class="glyph">-</span>She will receive an incentive spirometer, and its use will be reviewed.</p><p class="bulletIndent3"><span class="glyph">-</span>If there is concern for malnutrition, she will receive preoperative nutritional supplements.</p><p class="bulletIndent3"><span class="glyph">-</span>Postoperatively, she will plan to spend one night in the hospital.</p><p class="bulletIndent3"><span class="glyph">-</span>She should be able to eat a regular diet and ambulate beginning the night of surgery.</p><p class="bulletIndent3"><span class="glyph">-</span>Following that, she should ambulate in the hallway three times per day.</p><p class="bulletIndent3"><span class="glyph">-</span>She will receive scheduled pain medications before and after surgery to provide pain control and reduce the need for opioid use, with fewer adverse side effects.</p><p class="bulletIndent3"><span class="glyph">-</span>She will receive scheduled medications to promote bowel function.</p><p class="bulletIndent3"><span class="glyph">-</span>The plan for discharge the morning after surgery will be reviewed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Written information</strong> – Patients receive a brochure summarizing the ERAS elements and answering frequently asked questions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phone call</strong> – On the night before surgery, patients are contacted by a nurse in the surgical scheduling division to remind them of the preoperative dietary guidelines and to ensure they are consuming the preoperative drink as instructed.</p><p></p><p class="headingAnchor" id="H1607229361"><span class="h3">Health status optimization</span><span class="headingEndMark"> — </span>Preoperative optimization of medical comorbidities, including cardiovascular, respiratory, and/or renal disease, are typically part of ERAS programs and are discussed in separate topics: </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6615.html" rel="external">"Management of cardiac risk for noncardiac surgery"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/94539.html" rel="external">"Preoperative evaluation for anesthesia for noncardiac surgery"</a>.)</p><p></p><p>Examples specific to gynecologic surgery include correction of anemia and improved glucose control [<a href="#rid9">9</a>]. In addition, patients should be screened for tobacco, alcohol, and other substance use or abuse. Some experts advise patients to stop tobacco and alcohol use four weeks prior to surgery [<a href="#rid9">9</a>]. Reduced postoperative complication rates have been demonstrated with cessation of alcohol consumption [<a href="#rid14">14</a>]. While smoking cessation may not improve surgical outcomes, there is no risk to stopping and such counseling may encourage patients to quit altogether, particularly when adjunct pharmacotherapy is used [<a href="#rid15">15</a>]. Related information can be found in the following topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery", section on 'Preoperative evaluation'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14843.html" rel="external">"Screening for unhealthy use of alcohol and other drugs in primary care"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7809.html" rel="external">"Risky drinking and alcohol use disorder: Epidemiology, clinical features, adverse consequences, screening, and assessment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">"Overview of smoking cessation management in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16635.html" rel="external">"Pharmacotherapy for smoking cessation in adults"</a>.)</p><p></p><p class="headingAnchor" id="H1857618058"><span class="h3">Patient preparation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative fasting</strong> – ERAS pathways for gynecologic surgery typically allow consumption of solids up to six hours prior to anesthetic induction, clear liquids up to two hours prior to anesthetic induction, and encourage preoperative carbohydrate loading (<a class="graphic graphic_table graphicRef113769" href="/z/d/graphic/113769.html" rel="external">table 2</a>) [<a href="#rid9">9,16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bowel preparation</strong> – Mechanical bowel preparation is not indicated for most gynecologic surgery. (See  <a class="medical medical_review" href="/z/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery", section on 'Bowel preparation'</a> and  <a class="medical medical_review" href="/z/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery", section on 'Preoperative preparation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention of surgical site infections</strong> – In an attempt to reduce postoperative surgical site infections, surgical site infection reduction bundles are being incorporated into ERAS pathways to optimize postoperative patient outcomes. The United States Centers for Disease Control and Prevention guideline on surgical site infections advises that "before surgery, patients should shower or bathe (full body) with soap (antimicrobial or non-antimicrobial) or an antiseptic agent on at least the night before the operative day" [<a href="#rid17">17</a>]. Although the risk of infection following preoperative showering with 4% <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> gluconate alone prior to gynecologic surgery has not been studied in isolation, a lower risk of surgical site infection, from 6to 1.1 percent, was reported following implementation of preoperative showering with 4% chlorhexidine gluconate as part of a perioperative bundle among patients undergoing open uterine or ovarian cancer surgery [<a href="#rid18">18</a>]. Other elements of the bundle included patient education, 2% chlorhexidine gluconate and 70% isopropyl alcohol preparation of the planned area of incision, re-dosing of the prophylactic antibiotic at three to four hours following incision, sterile closing tray, staff glove change for abdominal wall closure, dressing removal at 24 to 48 hours postoperatively, postoperative showering at home with 4% chlorhexidine gluconate, and follow-up phone call by a nurse. As noted above, some practices provide the patient with the chlorhexidine cleansing soap or wipes to be used prior to surgery. Hair in the operative field should be clipped, not shaved, and skin is cleaned. (See <a class="local">'Patient education'</a> above.)</p><p></p><p class="bulletIndent1">Antibiotic prophylaxis is administered according to established guidelines. (See  <a class="medical medical_review" href="/z/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery", section on 'Preoperative evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative thromboprophylaxis</strong> – Preoperative thromboprophylaxis is administered according to established guidelines. (See  <a class="medical medical_review" href="/z/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery", section on 'Preoperative preparation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative analgesia</strong> – Patients in ERAS pathways usually receive preoperatively administered oral <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a>, and <a class="drug drug_general" data-topicid="8847" href="/z/d/drug information/8847.html" rel="external">celecoxib</a> with the goal of reducing postoperative pain (<a class="graphic graphic_table graphicRef113769" href="/z/d/graphic/113769.html" rel="external">table 2</a>) [<a href="#rid19">19</a>]. Other potential analgesic modalities include infiltration of the surgical site with local anesthetic, the possible use of transversus abdominis plane (TAP) blocks, or the possible use of neuraxial anesthesia (spinal or thoracic epidural anesthesia). In a systematic review of 46 studies assessing the role of nonopioid preoperative analgesia in women undergoing hysterectomy, patients treated with preoperative acetaminophen, gabapentin, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> (regional or local infiltration), and phenothiazine used less opioid compared with women treated with placebo [<a href="#rid20">20</a>]. While multiple nonopioid medications and combinations are available, the optimal treatment combination is not yet known and more than one combination may be effective. </p><p></p><p class="bulletIndent1">The multimodal approach to pain management is discussed below. (See <a class="local">'Multimodal analgesia and anesthesia'</a> below.) </p><p></p><p class="headingAnchor" id="H2428843600"><span class="h2">Intraoperative</span></p><p class="headingAnchor" id="H3715910513"><span class="h3">Multimodal analgesia and anesthesia</span><span class="headingEndMark"> — </span>Intraoperative elements of ERAS protocols are directed at both the anesthesia and surgical teams (<a class="graphic graphic_table graphicRef113768" href="/z/d/graphic/113768.html" rel="external">table 1</a>). Multimodal perioperative analgesia is a truly interdisciplinary ERAS intervention determined by both surgeons and anesthesiologists prior to the surgery. Potential interventions for consideration include the types of preoperative analgesia, quickest approach for the intended surgery, and opportunities to minimize physiologic disruption (eg, blood loss). Details of anesthetic management for adult patients undergoing surgery with ERAS are presented separately. (See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)"</a>.)</p><p>Importantly, elements of ERAS pathways will continue to evolve as new evidence emerges. As an example, <a class="drug drug_general" data-topicid="17057" href="/z/d/drug information/17057.html" rel="external">liposomal bupivacaine</a>, while not described in earlier ERAS pathways, has emerged as an adjunct for perioperative pain control when injected into surgical incisions or injected during a TAP block. Although data directly comparing liposomal bupivacaine use in direct surgical site infiltration versus liposomal bupivacaine use in TAP blocks remain limited, surgical site infiltration with liposomal bupivacaine is a low-risk intervention that appears to work synergistically within ERAS pathways to lower need for opioid analgesics [<a href="#rid21">21,22</a>] and has anecdotally worked well compared with ERAS alone in patients undergoing laparotomy at one author's institution.</p><p>Neuraxial anesthesia (ie, spinal or epidural anesthesia) has demonstrated efficacy regarding improved pain control and reduced postoperative opioid consumption in open gynecologic surgery. However, these potential benefits must be weighed against the potential risks of neuraxial anesthesia, including possible delayed time to ambulation and voiding, and increased hospital length of stay [<a href="#rid10">10</a>]. </p><p class="headingAnchor" id="H4090787074"><span class="h3">Interventions specific to the surgical team</span><span class="headingEndMark"> — </span>Potential ERAS interventions specific to the surgical team include selecting the least invasive route of surgery, determining the need for and duration of bladder catheterization, avoiding (or intraoperatively removing) nasogastric tubes, and minimizing the use of other drainage tubes (<a class="graphic graphic_table graphicRef113769" href="/z/d/graphic/113769.html" rel="external">table 2</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Route of surgery</strong> – Surgeons are advised to perform the least invasive surgery to address the problem. As an example, consistent with society guidelines, the vaginal approach is the preferred route for hysterectomy, followed by laparoscopy, and lastly, abdominal surgery if the other routes are not feasible [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bladder catheterization</strong> – Bladder catheters should be utilized for the shortest duration necessary. One strategy for minimizing bladder catheter use is to utilize straight catheterization for procedures in which prolonged postoperative drainage is not anticipated. When the bladder catheter is left in place, a voiding trial should be performed on postoperative day 0 or postoperative day 1, depending on the type of gynecologic surgery, for non-radical hysterectomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nasogastric tubes</strong> – Routine use of nasogastric tubes should be avoided, but if used, a nasogastric tube should be removed at the conclusion of the operation [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraperitoneal drainage tubes</strong> – Routine use of intraperitoneal drainage tubes should be avoided [<a href="#rid10">10</a>].</p><p></p><p class="headingAnchor" id="H4160099977"><span class="h3">Interventions specific to the anesthesia team</span><span class="headingEndMark"> — </span>At the time of preoperative briefing in the operating room, applicable ERAS elements are discussed among the surgical, anesthesiology, and nursing teams. Potential ERAS interventions specific to the anesthesia team include use of short-acting anesthetic agents, lung protective ventilation strategies, maintenance of normothermia, standardized prophylaxis for postoperative nausea and vomiting, and perioperative euvolemia (<a class="graphic graphic_table graphicRef113769" href="/z/d/graphic/113769.html" rel="external">table 2</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>To reduce postoperative nausea/vomiting, the ERAS Society recommends administering two classes of antiemetics intraoperatively as prophylaxis and adding a third class of drugs if postoperative nausea and vomiting is experienced [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The rationale for perioperative normovolemia/euvolemia is that excessive perioperative fluid administration is believed to be associated with numerous physiologic disruptions that impair recovery, including cardiopulmonary complications, impaired gut motility secondary to bowel edema, and impaired wound healing [<a href="#rid24">24</a>]. A meta-analysis found decreased postoperative morbidity when perioperative euvolemia was achieved with goal-directed fluid therapy in colorectal surgery [<a href="#rid25">25</a>]. A retrospective cohort study of an ERAS pathway in gynecologic surgery reported reduced opioid use and shorter length-of-stay for patients in the pathway, which included restrictive intravenous fluid resuscitation, with no increase in adverse events such as renal failure or [<a href="#rid26">26</a>].</p><p></p><p>A detailed discussion of the use of short-acting anesthetic agents, standardized ventilation strategies, maintenance of normothermia, by the anesthesia team is presented elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">"Enhanced recovery after colorectal surgery"</a> and  <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">"Enhanced recovery after colorectal surgery", section on 'Intraoperative strategies'</a>.)</p><p class="headingAnchor" id="H3075764366"><span class="h2">Postoperative</span><span class="headingEndMark"> — </span>Postoperative ERAS elements typically focus on pain management, bowel function, diet, and patient mobilization (<a class="graphic graphic_table graphicRef113768" href="/z/d/graphic/113768.html" rel="external">table 1</a>). Patients undergoing gynecologic surgery for benign indications are typically expected to be discharged within one to two days following surgery. A standardized, streamlined order set can facilitate execution of important postoperative interventions such as initiating the regular diet, bowel regimen, and ambulation on postoperative day 0 (<a class="graphic graphic_table graphicRef113769" href="/z/d/graphic/113769.html" rel="external">table 2</a>). Patient-controlled analgesia (PCA) is avoided, and patients are started on scheduled oral <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> and nonsteroidal anti-inflammatory drugs, with oral <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">oxycodone</a> for breakthrough pain. Only those patients who have persistent pain despite the above regimen receive intravenous opioids. PCA is begun only after all other options have been inadequate for pain control, which is rare.</p><p>Establishing a bladder management plan early in the postoperative care process facilitates discharge planning. In cases where a transurethral or suprapubic catheter is being used to drain the bladder, trial of voiding and/or catheter training should be conducted early on postoperative day 1, or even preoperatively, if applicable.</p><p>For vaginal prolapse repair, abdominal sacrocolpopexy, robotic sacrocolpopexy (with or without hysterectomy, sling), we take the following approach based on a prospective study of women undergoing prolapse surgery that reported no change in patient satisfaction with reduced postoperative opioid prescribing [<a href="#rid27">27</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>If a patient needed no opioids during the hospitalization, she can be sent home without an opioid prescription (0 tablets).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a patient needs the routine opioids ordered in the hospital order set, she is prescribed 15 tablets of <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">oxycodone</a> 5 mg (or equivalent dosing of another opioid).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a patient needs more than the routine opioids ordered in the hospital set, postoperative opioid prescribing is individualized.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Women with isolated slings are prescribed 10 tablets of <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">oxycodone</a> 5 mg.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lastly, we counsel all patients to dispose all unused opioids by either bringing them to the nearest Drug Enforcement Administration authorized collector or by flushing them down the toilet. Authorized collectors can be found <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fapps.deadiversion.usdoj.gov%2Fpubdispsearch%2Fspring%2Fmain%3Fexecution%3De1s1&amp;token=WaIbgYi8kJ3wxljNFBzdD4FoURE7Wwg11nN9V82eJLOmAlli57TqT2XEqEWGgawzJEXSMp4SQdrSn%2FFIcD7vxaImJQF%2BrGMJexPHRNKJHvk%3D&amp;TOPIC_ID=113714" target="_blank">online</a>.</p><p></p><p class="headingAnchor" id="H3551792268"><span class="h2">Discharge</span><span class="headingEndMark"> — </span>Criteria for discharge for any patient undergoing gynecologic surgery include tolerance of a regular diet, ambulation, and pain control with oral pain medications. For patients on an ERAS pathway, it is helpful to identify any potential barriers to discharge prior to surgery when known, or as soon as feasible following surgery. It is the authors' practice to identify for the nursing staff all patients planned to undergo discharge on postoperative day 1 using a "predischarge" or "conditional discharge" order so that the nursing and case management teams can ensure that discharge readiness goals are met. At the time of discharge, patient education is conducted by the nursing team, which consists of a review of the elements discussed preoperatively. </p><p class="headingAnchor" id="H125666338"><span class="h2">Postoperative follow-up</span><span class="headingEndMark"> — </span>In addition to conventional postoperative office visits with the surgeon, a follow-up telephone call shortly after the patient’s arrival home can decrease patient anxiety, answer questions, review instructions, provide reassurance, identify potential problems or complications as they arise, facilitate the patient’s transition from the hospital to the home environment, and potentially reduce preventable calls to the hospital and/or emergency department visits [<a href="#rid28">28</a>]. At the authors' institutions, such a postoperative phone call is typically conducted by a nurse or clinician within one to two days of discharge. This concept is also being increasingly applied to same-day (ambulatory) surgery. </p><p>As ERAS programs continue to evolve, some programs are evaluating smartphone apps as an additional tool to facilitate communication between patients and clinicians post-hospital discharge [<a href="#rid29">29-32</a>].</p><p class="headingAnchor" id="H1255857432"><span class="h1">OUTCOMES</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benefits</strong> – When compared with traditional postoperative care, ERAS protocols have been associated with decreased pain, opioid use, length of stay, use of nursing time, and cost, while simultaneously improving functional outcomes, patient satisfaction, and quality of life [<a href="#rid26">26,33,34</a>]. Benefits have been reported for women undergoing gynecologic procedures for cytoreduction, surgical staging, pelvic organ prolapse repair, and for minimally invasive transabdominal gynecologic surgery (ie, laparoscopy or robot-assisted laparoscopy) [<a href="#rid26">26,35-40</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Decreased pain and opioid use</strong> – ERAS protocols have been associated with decreased pain and opioid use. In one retrospective study of patients undergoing open surgery for gynecologic malignancy, when compared with patients receiving routine postoperative care, patients in the ERAS pathway used 44 percent fewer opioids and 36 percent less patient-controlled analgesia [<a href="#rid41">41</a>]. In another retrospective study that included women undergoing cytoreductive surgery, surgical staging for gynecologic malignancy, or transvaginal prolapse repair, ERAS use resulted in a four day reduction in hospital stay and less opioid use with similar readmission and postoperative complication rates when compared with historic care [<a href="#rid26">26</a>]. The decrease in opioid use reported with ERAS pathways has also been associated with stable or decreased pain scores in different postoperative phases of care [<a href="#rid26">26,41</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Length of stay</strong> – Studies of ERAS protocols for gynecologic surgery have mostly reported decreased length of stay compared with traditional postoperative care [<a href="#rid4">4,26,33,36,37,39,42-49</a>]. Reductions have been reported for women undergoing cytoreductive surgery (two to three days) [<a href="#rid26">26,42,46-48</a>], surgical staging (one day) [<a href="#rid26">26</a>], vaginal surgery (one day) [<a href="#rid26">26,43,50</a>], and open benign gynecologic surgery (one to two days) [<a href="#rid44">44,45</a>]. Although one trial of women undergoing laparotomy for gynecologic cancer did not report a reduction in length of stay for the ERAS program compared with routine care, the routine care group was not strictly defined and "permitted the use of any or all enhanced recovery after surgery tenets" [<a href="#rid51">51</a>]. In a separate retrospective cohort study of patients undergoing open surgery for gynecologic malignancy, length of stay decreased by &gt;3 days compared with historic controls [<a href="#rid52">52</a>]. In another study, in which &gt;85 percent of patients undergoing surgery for gynecologic malignancy underwent surgery via a minimally invasive route, a reduction in length of stay of 0.5 days was observed following the implementation of an enhanced recovery pathway when compared with historic controls [<a href="#rid53">53</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cost reduction</strong> – ERAS protocols have been associated with decreased cost compared with traditional postoperative care, even for open surgery or suspected malignancy [<a href="#rid26">26,48,50,54,55</a>]. Cost reduction reflects the decreased use of medication, nursing resources, and length of stay. In one retrospective cohort study of women undergoing cytoreductive surgery, women in the ERAS protocol had reduced total 30-day costs of &gt;$7600 USD per patient compared with the routine care group [<a href="#rid26">26</a>]. In the same study, &gt;$3000 USD was saved per women undergoing vaginal surgery in the ERAS care group, although this difference was not statistically significant. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Improved functional outcomes </strong>–<strong> </strong>Even for women undergoing open abdominal surgery, ERAS pathways shorten the duration of postoperative fatigue and disability. In a retrospective cohort study of women undergoing open gynecologic surgery for both benign and malignant disease that compared an ERAS protocol with historic care, ERAS patients reported a faster return to "no or mild fatigue" (10 versus 30 postoperative days), "no or mild interference with walking" (5 versus 13 days), and "mild to no total interference" (3 versus 13 days) [<a href="#rid56">56</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Unchanged surgical outcomes</strong> – Importantly, use of ERAS programs, and resultant early discharge, does not worsen surgical outcomes [<a href="#rid4">4,26</a>]. In a meta-analysis of studies comparing ERAS programs with traditional care among patients undergoing open surgery for both benign and malignant gynecologic disease, use of the ERAS protocol was not associated with increased morbidity, mortality, or readmission [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patient satisfaction and quality of life </strong>–<strong> </strong>ERAS protocols in gynecologic surgery are associated with high patient satisfaction scores for the overall patient perioperative care experience and for specific elements of care, such as control of nausea and vomiting [<a href="#rid26">26,57</a>]. Compared with patients receiving traditional care, patients on an enhanced recovery pathway reported higher measures of quality of life [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Concerns</strong> – Initial concerns that reduced length of stay would decrease patient access to information and education and increase postoperative complications or readmissions have generally not been validated [<a href="#rid4">4,33,58</a>]. A retrospective analysis of 258 women undergoing pelvic reconstructive surgery reported similar 30 day postoperative complication rates pre- and post-ERAS implementation, but ERAS patients did have higher 30-day readmission rates (6.7 versus 1.5 percent) [<a href="#rid37">37</a>]. The main challenges to ERAS implementation are the time and cost to establish ERAS programs [<a href="#rid42">42</a>]. </p><p></p><p class="headingAnchor" id="H3969366073"><span class="h1">IMPLEMENTATION</span><span class="headingEndMark"> — </span>Successful implementation of an ERAS program requires a multidisciplinary team effort as well as active participation by the patient [<a href="#rid5">5</a>]. Initiation of such a pathway in a timely, cost-effective manner can be logistically challenging (<a class="graphic graphic_table graphicRef113783" href="/z/d/graphic/113783.html" rel="external">table 3</a>) [<a href="#rid5">5,59</a>]. That said, without active implementation, diffusion of some or most best-practice elements of enhanced recovery can take years to occur [<a href="#rid7">7,42</a>]. A coordinated, multidisciplinary effort is required not only for the program creation but also to determine the outcomes that will be tracked prospectively as part of a quality improvement initiative [<a href="#rid3">3,43,49</a>]. When developing an ERAS program, it can be helpful to reach out to an institution that has successfully implemented ERAS.</p><p class="headingAnchor" id="H3967670696"><span class="h2">Stakeholders</span><span class="headingEndMark"> — </span>The successful execution of an enhanced recovery pathway involves coordinated efforts and education across multiple departments and members of the health care team, also known as "stakeholders." Stakeholders include [<a href="#rid8">8-10,60</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients, as the recipients of the interventions in the enhanced recovery pathway</p><p class="bulletIndent1"><span class="glyph">●</span>Surgeon's office, including surgical scheduler, nurse team</p><p class="bulletIndent1"><span class="glyph">●</span>Gynecologic surgeon and surgical team, including advanced practice providers and trainees</p><p class="bulletIndent1"><span class="glyph">●</span>Anesthesiologist and anesthesia team, including nurse anesthetists</p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative, intraoperative, and postoperative nursing teams</p><p class="bulletIndent1"><span class="glyph">●</span>Inpatient pharmacists</p><p class="bulletIndent1"><span class="glyph">●</span>Information technology (IT) department</p><p></p><p>Institutional and departmental steering committees can facilitate inclusion of stakeholders to ensure that everyone agrees upon the goal of establishing and executing an institutional enhanced recovery pathway. Following buy-in, the steering committee then guides the implementation of the agreed-upon ERAS protocol [<a href="#rid8">8</a>]. Such a steering committee typically consists of senior representatives from the stakeholder groups listed above, a project manager for the hospital and the departments, as well as representatives from the different surgical subspecialties (<a class="graphic graphic_table graphicRef113783" href="/z/d/graphic/113783.html" rel="external">table 3</a>).</p><p class="headingAnchor" id="H3424203377"><span class="h2">Timeline</span><span class="headingEndMark"> — </span>The following is an example of a project management grid outlining implementation of an ERP over a four-month period in a gynecology division at an urban academic hospital (<a class="graphic graphic_table graphicRef113783" href="/z/d/graphic/113783.html" rel="external">table 3</a>). Steps of implementation, along with key stakeholders for each step, are identified. The project management timeline can be adapted based on the needs and resources of the individual institution.</p><p>Upon the identification of a "Clinical Go-Live" date, steps can be generally applied as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Prior to Go-Live:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Establish Steering Committee representatives; identify literature and ERAS program resources for dissemination within department and steering committee.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Read specialty-specific ERAS literature.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Establish intra-department consensus on ERAS program target populations and elements for adoption.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Meet to obtain interdisciplinary consensus on ERAS elements and executors. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Work on order sets with IT department; announce initiative to departments/stakeholders.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Plan site(s) of preoperative education, the specific preoperative patient education materials, and the preoperative letter.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Create formal educational materials for surgeons, anesthesiologists, and nurses containing rationale and ERAS elements.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Begin mailing new preoperative letter; surgeons begin scheduling patients as "ERAS."</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Send reminders of scheduling ERAS surgical patients, preoperative ordering, and Go-Live dates to all stakeholders.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preoperative patient education begins/obtain preoperative drink.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sign off on order sets. </p><p></p><p class="bulletIndent2">Active participation by all members of the surgical team is critical to achieving success. To that end, it can be helpful to have a division or another institution who has implemented ERAS present the program’s benefits and address any concerns. Additionally, the institution may elect to pilot the program and use the preliminary data to educate others regarding the benefits of implementing the practice change prior to a larger-scale rollout. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Go-Live:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Perioperative briefings</p><p class="bulletIndent2"><span class="glyph">•</span>Use perioperative order sets</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following Go-Live:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Conduct periodic clinical huddles/education</p><p class="bulletIndent2"><span class="glyph">•</span>Conduct Quality Improvement data collection/audits</p><p class="bulletIndent2"><span class="glyph">•</span>Adaptation and incorporation of new evidence and best practices</p><p></p><p class="headingAnchor" id="H599926644"><span class="h2">Metrics</span><span class="headingEndMark"> — </span>As with any quality improvement initiative, ongoing implementation and clinical audits are important. Hospitals can conduct quality improvement audits independently; however, the ERAS Society has developed an audit tool to facilitate the study of implementation and clinical outcomes [<a href="#rid3">3</a>]. </p><p>The following are examples of implementation-specific metrics, or process measures:</p><p class="bulletIndent1"><span class="glyph">●</span>Proportion of enhanced recovery-eligible patients who were placed on an enhanced recovery pathway </p><p class="bulletIndent1"><span class="glyph">●</span>Proportion of enhanced recovery pathway participants who received specific elements of the enhanced recovery pathway</p><p></p><p>The following are examples of clinical metrics:</p><p class="bulletIndent1"><span class="glyph">●</span>Length of hospital stay</p><p class="bulletIndent1"><span class="glyph">●</span>Cost of hospital stay</p><p class="bulletIndent1"><span class="glyph">●</span>Perioperative opioid use</p><p class="bulletIndent1"><span class="glyph">●</span>Perioperative fluid balance</p><p class="bulletIndent1"><span class="glyph">●</span>Perioperative pain scores</p><p class="bulletIndent1"><span class="glyph">●</span>Postoperative day of first ambulation</p><p class="bulletIndent1"><span class="glyph">●</span>Performance of ambulation three times per day</p><p class="bulletIndent1"><span class="glyph">●</span>Postoperative day of tolerance of regular diet</p><p class="bulletIndent1"><span class="glyph">●</span>Time to resumption of voiding function</p><p class="bulletIndent1"><span class="glyph">●</span>Postoperative day of resumption of bowel function</p><p class="bulletIndent1"><span class="glyph">●</span>Patient satisfaction</p><p class="bulletIndent1"><span class="glyph">●</span>Unanticipated emergency department visit and/or readmission</p><p class="bulletIndent1"><span class="glyph">●</span>Postoperative infection (urinary tract infection, surgical site infection)</p><p class="bulletIndent1"><span class="glyph">●</span>Ileus</p><p></p><p>Balancing measures, or adverse outcomes of the process change, should be included as metrics, for example:</p><p class="bulletIndent1"><span class="glyph">●</span>Proportion of patients experiencing an adverse reaction to a medication or intervention on the enhanced recovery pathway</p><p></p><p>Most of these metrics can be collected from the electronic medical record by members of a dedicated ERAS Quality Improvement team, including surgeons, fellows, residents, clinical research nurses, medical students, and/or a dedicated study coordinator. At the authors' institutions, the IT departments are able to produce automated reports of some of the metrics to accelerate data collection. Data, which are collected out to 30 postoperative days for each patient, are reviewed on a monthly basis by the ERAS team leaders as well as by the steering committee. If an ERAS component or metric is not progressing in the desired direction, an intervention can be quickly undertaken. To fully assess the impact of implementation of an ERAS protocol, it is beneficial to compare the results following of ERAS implementation with an historic cohort of similar patients from the same institution that were treated prior to the implementation.</p><p class="headingAnchor" id="H1413588038"><span class="h1">RESOURCES FOR PATIENTS AND CLINICIANS</span></p><p class="bulletIndent1"><span class="glyph">●</span>The <a class="external" href="/external-redirect?target_url=http%3A%2F%2Ferassociety.org%2F&amp;token=FJGQbPUEIkpxW92AoS3a%2Bc5UA%2FDZ6c1oN84z1Glvkfg%3D&amp;TOPIC_ID=113714" target="_blank">ERAS Society</a> provides clinical guidelines in different subspecialties, including gynecologic surgery, as well as implementation and audit resources, all available online.</p><p></p><p class="headingAnchor" id="H2554339750"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Enhanced recovery after surgery (ERAS) programs combine evidence-based elements of care during the pre-, intra-, and postoperative experiences to decrease physiological stress and organ dysfunction, and thus, enable patients to recover more quickly, have decreased hospital length of stay, and resume routine activity more quickly than with standard surgical care. Importantly, elements of ERAS pathways will continue to evolve as new evidence emerges. (See <a class="local">'Definition'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients undergoing planned gynecologic surgery with an overnight stay are candidates for participation in an ERAS protocol. Although an ERAS pathway can broadly apply to the majority of patients undergoing gynecologic surgery, such a pathway should always be individualized when and where medically indicated. (See <a class="local">'Candidates'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In general, enhanced recovery focuses on optimizing patient education and perioperative expectations, decreasing the perioperative fasting period, maintaining euvolemia and normothermia, increasing mobilization, providing multimodal pain relief, providing multimodal nausea and vomiting prophylaxis, and decreasing unnecessary or prolonged use of catheters and drains. A guideline of general components for gynecologic surgery has been published by the ERAS Society (<a class="graphic graphic_table graphicRef113768" href="/z/d/graphic/113768.html" rel="external">table 1</a>), and modifications have been suggested for patients with gynecologic malignancy. (See <a class="local">'Components'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preoperative ERAS elements include specific patient education instructions (verbal and written), health status optimization, preoperative patient preparation. (See <a class="local">'Preoperative'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intraoperative elements of ERAS protocols are directed at both the anesthesia and surgical teams (<a class="graphic graphic_table graphicRef113768" href="/z/d/graphic/113768.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef113769" href="/z/d/graphic/113769.html" rel="external">table 2</a>). Both the anesthesia team and surgeons perform interventions aimed at perioperative pain control. Potential ERAS interventions for the anesthesia team also include use of short-acting anesthetic agents, standardized ventilation strategies, standardized prophylaxis for postoperative nausea and vomiting, maintenance of normothermia and euvolemia, and avoidance (or intraoperative removal) of nasogastric tubes. Surgeons are advised to perform the least invasive surgery to address the problem. (See <a class="local">'Intraoperative'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Postoperative ERAS elements typically focus on pain management, bowel function, diet, and patient mobilization (<a class="graphic graphic_table graphicRef113768" href="/z/d/graphic/113768.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef113769" href="/z/d/graphic/113769.html" rel="external">table 2</a>). Patients undergoing gynecologic surgery should typically expect to be discharged within one to two days following surgery. (See <a class="local">'Postoperative'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Criteria for discharge for any patient undergoing gynecologic surgery include tolerance of a regular diet, ambulation, and pain control with oral pain medications. For patients on an ERAS pathway, it is helpful to identify any potential barriers to discharge prior to surgery when known, or as soon as feasible following surgery. (See <a class="local">'Discharge'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When compared with traditional postoperative care, ERAS protocols have been associated with decreased pain, length of stay, use of nursing time, and cost, while simultaneously improving patient satisfaction and quality of life. (See <a class="local">'Outcomes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Successful implementation of an ERAS program requires a multidisciplinary team effort as well as active participation by the patient. Initiation of such a pathway in a timely, cost-effective manner can be logistically challenging (<a class="graphic graphic_table graphicRef113783" href="/z/d/graphic/113783.html" rel="external">table 3</a>). That said, without active implementation, diffusion of some or most best-practice elements of enhanced recovery can take years to occur. When developing an ERAS program, it can be helpful to reach out to an institution that has successfully implemented ERAS. (See <a class="local">'Implementation'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Scientific Impact Paper No. 36. Enhanced Recovery in Gynaecology. Royal College of Obstetricians and Gynaecologists. February, 2013. https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_36.pdf (Accessed on June 27, 2017).</li><li><a class="nounderline abstract_t">Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997; 78:606.</a></li><li class="breakAll">www.erassociety.org (Accessed on June 22, 2017).</li><li><a class="nounderline abstract_t">de Groot JJ, Ament SM, Maessen JM, et al. Enhanced recovery pathways in abdominal gynecologic surgery: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2016; 95:382.</a></li><li><a class="nounderline abstract_t">Miralpeix E, Nick AM, Meyer LA, et al. A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs. Gynecol Oncol 2016; 141:371.</a></li><li><a class="nounderline abstract_t">Modesitt SC, Sarosiek BM, Trowbridge ER, et al. Enhanced Recovery Implementation in Major Gynecologic Surgeries: Effect of Care Standardization. Obstet Gynecol 2016; 128:457.</a></li><li><a class="nounderline abstract_t">Muallem MZ, Dimitrova D, Pietzner K, et al. Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany. Anticancer Res 2016; 36:4227.</a></li><li><a class="nounderline abstract_t">Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg 2017; 152:292.</a></li><li><a class="nounderline abstract_t">Nelson G, Altman AD, Nick A, et al. Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I. Gynecol Oncol 2016; 140:313.</a></li><li><a class="nounderline abstract_t">Nelson G, Altman AD, Nick A, et al. Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part II. Gynecol Oncol 2016; 140:323.</a></li><li><a class="nounderline abstract_t">Nelson G, Dowdy SC, Lasala J, et al. Enhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development. Gynecol Oncol 2017; 147:617.</a></li><li><a class="nounderline abstract_t">EGBERT LD, BATTIT GE, WELCH CE, BARTLETT MK. REDUCTION OF POSTOPERATIVE PAIN BY ENCOURAGEMENT AND INSTRUCTION OF PATIENTS. A STUDY OF DOCTOR-PATIENT RAPPORT. N Engl J Med 1964; 270:825.</a></li><li><a class="nounderline abstract_t">van der Meij E, Anema JR, Leclercq WKG, et al. Personalised perioperative care by e-health after intermediate-grade abdominal surgery: a multicentre, single-blind, randomised, placebo-controlled trial. Lancet 2018; 392:51.</a></li><li><a class="nounderline abstract_t">Oppedal K, Møller AM, Pedersen B, Tønnesen H. Preoperative alcohol cessation prior to elective surgery. Cochrane Database Syst Rev 2012; :CD008343.</a></li><li><a class="nounderline abstract_t">Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2014; :CD002294.</a></li><li><a class="nounderline abstract_t">Smith MD, McCall J, Plank L, et al. Preoperative carbohydrate treatment for enhancing recovery after elective surgery. Cochrane Database Syst Rev 2014; :CD009161.</a></li><li><a class="nounderline abstract_t">Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 2017; 152:784.</a></li><li><a class="nounderline abstract_t">Johnson MP, Kim SJ, Langstraat CL, et al. Using Bundled Interventions to Reduce Surgical Site Infection After Major Gynecologic Cancer Surgery. Obstet Gynecol 2016; 127:1135.</a></li><li><a class="nounderline abstract_t">Kalogera E, Dowdy SC. Enhanced Recovery Pathway in Gynecologic Surgery: Improving Outcomes Through Evidence-Based Medicine. Obstet Gynecol Clin North Am 2016; 43:551.</a></li><li><a class="nounderline abstract_t">Steinberg AC, Schimpf MO, White AB, et al. Preemptive analgesia for postoperative hysterectomy pain control: systematic review and clinical practice guidelines. Am J Obstet Gynecol 2017; 217:303.</a></li><li><a class="nounderline abstract_t">Kalogera E, Bakkum-Gamez JN, Weaver AL, et al. Abdominal Incision Injection of Liposomal Bupivacaine and Opioid Use After Laparotomy for Gynecologic Malignancies. Obstet Gynecol 2016; 128:1009.</a></li><li><a class="nounderline abstract_t">Gasanova I, Alexander J, Ogunnaike B, et al. Transversus Abdominis Plane Block Versus Surgical Site Infiltration for Pain Management After Open Total Abdominal Hysterectomy. Anesth Analg 2015; 121:1383.</a></li><li><a class="nounderline abstract_t">Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease. Obstet Gynecol 2017; 129:e155.</a></li><li><a class="nounderline abstract_t">Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002; 89:622.</a></li><li><a class="nounderline abstract_t">Rahbari NN, Zimmermann JB, Schmidt T, et al. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg 2009; 96:331.</a></li><li><a class="nounderline abstract_t">Kalogera E, Bakkum-Gamez JN, Jankowski CJ, et al. Enhanced recovery in gynecologic surgery. Obstet Gynecol 2013; 122:319.</a></li><li class="breakAll">Linder B, 2018, personal communication.</li><li><a class="nounderline abstract_t">Archer S, Montague J, Bali A. Exploring the experience of an enhanced recovery programme for gynaecological cancer patients: a qualitative study. Perioper Med (Lond) 2014; 3:2.</a></li><li><a class="nounderline abstract_t">Armstrong KA, Coyte PC, Brown M, et al. Effect of Home Monitoring via Mobile App on the Number of In-Person Visits Following Ambulatory Surgery: A Randomized Clinical Trial. JAMA Surg 2017; 152:622.</a></li><li><a class="nounderline abstract_t">Debono B, Bousquet P, Sabatier P, et al. Postoperative monitoring with a mobile application after ambulatory lumbar discectomy: an effective tool for spine surgeons. Eur Spine J 2016; 25:3536.</a></li><li><a class="nounderline abstract_t">Jaensson M, Dahlberg K, Eriksson M, et al. The Development of the Recovery Assessments by Phone Points (RAPP): A Mobile Phone App for Postoperative Recovery Monitoring and Assessment. JMIR Mhealth Uhealth 2015; 3:e86.</a></li><li><a class="nounderline abstract_t">Dahlberg K, Jaensson M, Eriksson M, Nilsson U. Evaluation of the Swedish Web-Version of Quality of Recovery (SwQoR): Secondary Step in the Development of a Mobile Phone App to Measure Postoperative Recovery. JMIR Res Protoc 2016; 5:e192.</a></li><li><a class="nounderline abstract_t">Sjetne IS, Krogstad U, Ødegård S, Engh ME. Improving quality by introducing enhanced recovery after surgery in a gynaecological department: consequences for ward nursing practice. Qual Saf Health Care 2009; 18:236.</a></li><li><a class="nounderline abstract_t">Wodlin NB, Nilsson L, Kjølhede P. Health-related quality of life and postoperative recovery in fast-track hysterectomy. Acta Obstet Gynecol Scand 2011; 90:362.</a></li><li><a class="nounderline abstract_t">Chapman JS, Roddy E, Ueda S, et al. Enhanced Recovery Pathways for Improving Outcomes After Minimally Invasive Gynecologic Oncology Surgery. Obstet Gynecol 2016; 128:138.</a></li><li><a class="nounderline abstract_t">Trowbridge ER, Dreisbach CN, Sarosiek BM, et al. Review of enhanced recovery programs in benign gynecologic surgery. Int Urogynecol J 2018; 29:3.</a></li><li><a class="nounderline abstract_t">Carter-Brooks CM, Du AL, Ruppert KM, et al. Implementation of a urogynecology-specific enhanced recovery after surgery (ERAS) pathway. Am J Obstet Gynecol 2018; 219:495.e1.</a></li><li><a class="nounderline abstract_t">Trowbridge ER, Evans SL, Sarosiek BM, et al. Enhanced recovery program for minimally invasive and vaginal urogynecologic surgery. Int Urogynecol J 2019; 30:313.</a></li><li><a class="nounderline abstract_t">Wijk L, Udumyan R, Pache B, et al. International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery. Am J Obstet Gynecol 2019; 221:237.e1.</a></li><li><a class="nounderline abstract_t">Peters A, Siripong N, Wang L, Donnellan NM. Enhanced recovery after surgery outcomes in minimally invasive nonhysterectomy gynecologic procedures. Am J Obstet Gynecol 2020; 223:234.e1.</a></li><li><a class="nounderline abstract_t">Bergstrom JE, Scott ME, Alimi Y, et al. Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementation. Gynecol Oncol 2018; 149:554.</a></li><li><a class="nounderline abstract_t">de Groot JJ, van Es LE, Maessen JM, et al. Diffusion of Enhanced Recovery principles in gynecologic oncology surgery: is active implementation still necessary? Gynecol Oncol 2014; 134:570.</a></li><li><a class="nounderline abstract_t">Barber EL, Van Le L. Enhanced Recovery Pathways in Gynecology and Gynecologic Oncology. Obstet Gynecol Surv 2015; 70:780.</a></li><li><a class="nounderline abstract_t">Dickson E, Argenta PA, Reichert JA. Results of introducing a rapid recovery program for total abdominal hysterectomy. Gynecol Obstet Invest 2012; 73:21.</a></li><li><a class="nounderline abstract_t">Miller EC, McIsaac DI, Chaput A, et al. Increased postoperative day one discharges after implementation of a hysterectomy enhanced recovery pathway: a retrospective cohort study. Can J Anaesth 2015; 62:451.</a></li><li><a class="nounderline abstract_t">Marx C, Rasmussen T, Jakobsen DH, et al. The effect of accelerated rehabilitation on recovery after surgery for ovarian malignancy. Acta Obstet Gynecol Scand 2006; 85:488.</a></li><li><a class="nounderline abstract_t">Eberhart LHJ, Koch T, Plöger B, et al. Enhanced recovery after major gynaecological surgery for ovarian cancer - An objective and patient-based assessment of a traditional versus a multimodal “fast track” rehabilitation programme. Anasth Intensivmed 2008; 49:180.</a></li><li><a class="nounderline abstract_t">Gerardi MA, Santillan A, Meisner B, et al. A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers. Gynecol Oncol 2008; 108:282.</a></li><li><a class="nounderline abstract_t">Nelson G, Kalogera E, Dowdy SC. Enhanced recovery pathways in gynecologic oncology. Gynecol Oncol 2014; 135:586.</a></li><li><a class="nounderline abstract_t">Yoong W, Sivashanmugarajan V, Relph S, et al. Can enhanced recovery pathways improve outcomes of vaginal hysterectomy? Cohort control study. J Minim Invasive Gynecol 2014; 21:83.</a></li><li><a class="nounderline abstract_t">Dickson EL, Stockwell E, Geller MA, et al. Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled Trial. Obstet Gynecol 2017; 129:355.</a></li><li><a class="nounderline abstract_t">Mendivil AA, Busch JR, Richards DC, et al. The Impact of an Enhanced Recovery After Surgery Program on Patients Treated for Gynecologic Cancer in the Community Hospital Setting. Int J Gynecol Cancer 2018; 28:581.</a></li><li><a class="nounderline abstract_t">Lambaudie E, de Nonneville A, Brun C, et al. Enhanced recovery after surgery program in Gynaecologic Oncological surgery in a minimally invasive techniques expert center. BMC Surg 2017; 17:136.</a></li><li><a class="nounderline abstract_t">Relph S, Bell A, Sivashanmugarajan V, et al. Cost effectiveness of enhanced recovery after surgery programme for vaginal hysterectomy: a comparison of pre and post-implementation expenditures. Int J Health Plann Manage 2014; 29:399.</a></li><li><a class="nounderline abstract_t">Harrison RF, Li Y, Guzman A, et al. Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs. Am J Obstet Gynecol 2020; 222:66.e1.</a></li><li><a class="nounderline abstract_t">Meyer LA, Lasala J, Iniesta MD, et al. Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes. Obstet Gynecol 2018; 132:281.</a></li><li><a class="nounderline abstract_t">Philp S, Carter J, Pather S, et al. Patients' satisfaction with fast-track surgery in gynaecological oncology. Eur J Cancer Care (Engl) 2015; 24:567.</a></li><li><a class="nounderline abstract_t">Keil DS, Schiff LD, Carey ET, et al. Predictors of Admission After the Implementation of an Enhanced Recovery After Surgery Pathway for Minimally Invasive Gynecologic Surgery. Anesth Analg 2019; 129:776.</a></li><li><a class="nounderline abstract_t">de Groot JJ, Maessen JM, Slangen BF, et al. A stepped strategy that aims at the nationwide implementation of the Enhanced Recovery After Surgery programme in major gynaecological surgery: study protocol of a cluster randomised controlled trial. Implement Sci 2015; 10:106.</a></li><li><a class="nounderline abstract_t">McDonald R. Enhanced recovery clinical education programme improves quality of post-operative care. BMJ Qual Improv Rep 2015; 4.</a></li></ol></div><div id="topicVersionRevision">Topic 113714 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_36.pdf" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Scientific Impact Paper No. 36. Enhanced Recovery in Gynaecology. Royal College of Obstetricians and Gynaecologists. February, 2013. https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_36.pdf (Accessed on June 27, 2017).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9175983" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Multimodal approach to control postoperative pathophysiology and rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9175983" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Multimodal approach to control postoperative pathophysiology and rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26613531" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Enhanced recovery pathways in abdominal gynecologic surgery: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26906066" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27500337" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Enhanced Recovery Implementation in Major Gynecologic Surgeries: Effect of Care Standardization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27466536" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28097305" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Enhanced Recovery After Surgery: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26603969" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26757238" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28947172" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Enhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14108087" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : REDUCTION OF POSTOPERATIVE PAIN BY ENCOURAGEMENT AND INSTRUCTION OF PATIENTS. A STUDY OF DOCTOR-PATIENT RAPPORT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29937195" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Personalised perioperative care by e-health after intermediate-grade abdominal surgery: a multicentre, single-blind, randomised, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22786514" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Preoperative alcohol cessation prior to elective surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24671929" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Interventions for preoperative smoking cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25121931" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Preoperative carbohydrate treatment for enhancing recovery after elective surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28467526" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27159744" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Using Bundled Interventions to Reduce Surgical Site Infection After Major Gynecologic Cancer Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27521884" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Enhanced Recovery Pathway in Gynecologic Surgery: Improving Outcomes Through Evidence-Based Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28351670" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Preemptive analgesia for postoperative hysterectomy pain control: systematic review and clinical practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27741199" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Abdominal Incision Injection of Liposomal Bupivacaine and Opioid Use After Laparotomy for Gynecologic Malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26252171" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Transversus Abdominis Plane Block Versus Surgical Site Infiltration for Pain Management After Open Total Abdominal Hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28538495" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12393365" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pathophysiology and clinical implications of perioperative fluid excess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19283742" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23969801" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Enhanced recovery in gynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23969801" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Enhanced recovery in gynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24708824" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Exploring the experience of an enhanced recovery programme for gynaecological cancer patients: a qualitative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28329223" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Effect of Home Monitoring via Mobile App on the Number of In-Person Visits Following Ambulatory Surgery: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27349754" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Postoperative monitoring with a mobile application after ambulatory lumbar discectomy: an effective tool for spine surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26362403" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The Development of the Recovery Assessments by Phone Points (RAPP): A Mobile Phone App for Postoperative Recovery Monitoring and Assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27679867" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Evaluation of the Swedish Web-Version of Quality of Recovery (SwQoR): Secondary Step in the Development of a Mobile Phone App to Measure Postoperative Recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19468009" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Improving quality by introducing enhanced recovery after surgery in a gynaecological department: consequences for ward nursing practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21306322" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Health-related quality of life and postoperative recovery in fast-track hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27275797" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Enhanced Recovery Pathways for Improving Outcomes After Minimally Invasive Gynecologic Oncology Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28871417" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Review of enhanced recovery programs in benign gynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29913175" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Implementation of a urogynecology-specific enhanced recovery after surgery (ERAS) pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30374533" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Enhanced recovery program for minimally invasive and vaginal urogynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31051119" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32087147" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Enhanced recovery after surgery outcomes in minimally invasive nonhysterectomy gynecologic procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29661495" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24983649" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Diffusion of Enhanced Recovery principles in gynecologic oncology surgery: is active implementation still necessary?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26676149" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Enhanced Recovery Pathways in Gynecology and Gynecologic Oncology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22156551" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Results of introducing a rapid recovery program for total abdominal hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25724789" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Increased postoperative day one discharges after implementation of a hysterectomy enhanced recovery pathway: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16612713" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The effect of accelerated rehabilitation on recovery after surgery for ovarian malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Enhanced recovery after major gynaecological surgery for ovarian cancer - An objective and patient-based assessment of a traditional versus a multimodal“fast track”rehabilitation programme</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18023851" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25316179" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Enhanced recovery pathways in gynecologic oncology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23850899" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Can enhanced recovery pathways improve outcomes of vaginal hysterectomy? Cohort control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28079776" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29466256" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The Impact of an Enhanced Recovery After Surgery Program on Patients Treated for Gynecologic Cancer in the Community Hospital Setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29282059" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Enhanced recovery after surgery program in Gynaecologic Oncological surgery in a minimally invasive techniques expert center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23661616" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cost effectiveness of enhanced recovery after surgery programme for vaginal hysterectomy: a comparison of pre and post-implementation expenditures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31376395" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29995737" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25335828" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Patients' satisfaction with fast-track surgery in gynaecological oncology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31425219" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Predictors of Admission After the Implementation of an Enhanced Recovery After Surgery Pathway for Minimally Invasive Gynecologic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26223232" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A stepped strategy that aims at the nationwide implementation of the Enhanced Recovery After Surgery programme in major gynaecological surgery: study protocol of a cluster randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26734343" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Enhanced recovery clinical education programme improves quality of post-operative care.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
